Cohance Lifesciences Ltd.
COHANCE Share PricePharmaceuticals & Drugs
₹549.1
5.4 (1%)
As on December 4, 2025
Exchange Scrips: BSE543064NSECOHANCEISININE03QK01018
Market Cap ₹ 21,016 Cr
P/E Ratio 52.19
Dividend Yield N/A
Performance
Market performance
Open545.65
High550.15
Volumes3,03,345
Prev549.1
Low540.35
As on2025-12-04
Historical performance
1 Year High1,342
3 Year High1,360
5 Year High1,360
1 Year Low540.35
3 Year Low456
5 Year Low385
Fundamentals
Company Valuation
Market Cap (₹Cr)
21,016
Face Value (₹)
1
P/E Ratio
52.19
Dividend Yield
N/A
Investment Returns
1 Year
-57.7%
3 Years
17.5%
5 Years
42.5%
10 Years
N/A
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 551.12 | Bearish |
| 10-DMA | 561.84 | Bearish |
| 20-DMA | 601.42 | Bearish |
| 50-DMA | 753.85 | Bearish |
| 100-DMA | 860.96 | Bearish |
| 200-DMA | 977.52 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 2 | 2 | 1 | 1 | 1 |
| Foreign Investors | 2 | 2 | 1 | 1 | 1 |
| Domestic Investors | --- | --- | --- | --- | --- |
| Public Investors | 75282 | 80908 | 86324 | 84209 | 69336 |
| Government | 1 | 1 | 1 | 1 | 1 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 52.19.
- 3Y Stock Price CAGR of the stock is 5.8.
- The stock has a beta of 0.6.
- In the last financial year, the company had an EBITDA of ₹4338 Million.
- The company generated revenue of ₹11976 Million in the previous financial year.
Cohance Lifesciences Ltd.
549.15.4 (1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 423606.6
No. of Shares: 771 (Approx)
Performance:-57.6%
P/L: ₹-576393.4
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
